Acute lung failure

Seminars in Respiratory and Critical Care Medicine

Volumn 32, Issue 5, 2011, Pages 607-625

  Sweeney, Rob Mac ^a,b   McAuley, Daniel F ^a,b   Matthay, Michael A ^c,d  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b ROYAL VICTORIA HOSPITAL   (United Kingdom)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

acute lung injury; acute respiratory distress syndrome; asthma; bronchitis; emphysema; Guillain Barr syndrome; myasthenia gravis; pneumonia; pulmonary edema; pulmonary embolism; Respiratory failure

Indexed keywords

ACTIVATED PROTEIN C; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; AMINOPENICILLIN; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRAIN NATRIURETIC PEPTIDE; CORTICOSTEROID; DOXAPRAM; FISH OIL; GLUCOCORTICOID; HYDROCORTISONE; IPRATROPIUM BROMIDE; KETOCONAZOLE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LISOFYLLINE; MACROLIDE; MAGNESIUM SULFATE; PENTOXIFYLLINE; SALBUTAMOL; SURFACTANT; TERBUTALINE; TETRACYCLINE;

ACUTE LUNG INJURY; ACUTE RESPIRATORY FAILURE; ARTIFICIAL VENTILATION; ASTHMA; BACTEREMIA; BILEVEL POSITIVE AIRWAY PRESSURE; BLOOD CARBON DIOXIDE TENSION; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPUTER ASSISTED TOMOGRAPHY; DRUG EFFICACY; ECHOCARDIOGRAPHY; EXTRACORPOREAL OXYGENATION; GUILLAIN BARRE SYNDROME; HUMAN; IMMUNOTHERAPY; INCIDENCE; INTENSIVE CARE UNIT; LUNG EDEMA; LUNG EMBOLISM; LUNG FUNCTION; MORTALITY; MULTIDETECTOR COMPUTED TOMOGRAPHY; MYASTHENIA GRAVIS; NEBULIZATION; OXYGEN THERAPY; PATIENT POSITIONING; PH; PLASMAPHERESIS; POSITIVE END EXPIRATORY PRESSURE; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; THORAX RADIOGRAPHY; TOPICAL ANESTHESIA; TREATMENT DURATION; VENTILATOR ASSOCIATED PNEUMONIA;

ACUTE DISEASE; ACUTE LUNG INJURY; CRITICAL CARE; CRITICAL ILLNESS; HUMANS; INTENSIVE CARE UNITS; MULTIPLE ORGAN FAILURE; RESPIRATORY INSUFFICIENCY;

EID: 80054083750     PISSN: 10693424     EISSN: 10989048     Source Type: Journal    
DOI: 10.1055/s-0031-1287870     Document Type: Review

References (280)

1. Vincent J-L, de Mendonça A, Cantraine F et al. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on sepsis-related problems of the European Society of Intensive Care Medicine. Crit Care Med 1998 26 11 1793-1800 (Pubitemid 28527688)
2. Vincent J-L, Akça S, De Mendonça A et al, SOFA Working Group. Sequntial organ failure assessment. The epidemiology of acute respiratory failure in critically ill patients(*). Chest 2002 121 5 1602-1609 (Pubitemid 34499677)
3. Hadden R DM, Cornblath D R., Hughes R AC et al, Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group. Electrophysiological classification of Guillain-Barré syndrome: clinical associations and outcome. Ann Neurol 1998 44 5 780-788 (Pubitemid 28516049)
4. Hughes R A., Cornblath D R. Guillain-Barré syndrome. Lancet 2005 366 9497 1653-1666
5. Winer J B. Guillain-Barré syndrome. BMJ 2008 337 a671 doi: 10.1136/bmj.a671. Review. No abstract available 227231
6. The prognosis and main prognostic indicators of Guillain-Barré syndrome: a multicentre prospective study of 297 patients. The Italian Guillain-Barré Study Group. Brain 1996 119 Pt 6 2053-2061
7. Chaudhuri A, Behan P O. Myasthenic crisis. QJM 2009 102 2 97-107
8. McGrogan A, Sneddon S, de Vries C S. The incidence of myasthenia gravis: a systematic literature review. Neuroepidemiology 2010 34 3 171-183
9. Phillips L H. II. The epidemiology of myasthenia gravis. Ann N Y Acad Sci 2003 998 407-412 (Pubitemid 37194192)
10. Alshekhlee A, Miles J D., Katirji B, Preston D C., Kaminski H J. Incidence and mortality rates of myasthenia gravis and myasthenic crisis in US hospitals. Neurology 2009 72 18 1548-1554
11. Asbury A K., Cornblath D R. Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann Neurol 1990 27 Suppl S21-S24 (Pubitemid 20178648)
12. Bershad E M., Feen E S., Suarez J I. Myasthenia gravis crisis. South Med J 2008 101 1 63-69
13. Racca F, Del Sorbo L, Mongini T, Vianello A, Ranieri V M. Respiratory management of acute respiratory failure in neuromuscular diseases. Minerva Anestesiol 2010 76 1 51-62
14. Mehta S. Neuromuscular disease causing acute respiratory failure. Respir Care 2006 51 9 1016-1021 discussion 1021-1023 (Pubitemid 44870532)
15. Putman M T., Wise R A. Myasthenia gravis and upper airway obstruction. Chest 1996 109 2 400-404 (Pubitemid 26058595)
16. Rieder P, Louis M, Jolliet P, Chevrolet J C. The repeated measurement of vital capacity is a poor predictor of the need for mechanical ventilation in myasthenia gravis. Intensive Care Med 1995 21 8 663-668
17. Sharshar T, Chevret S, Bourdain F, Raphaël J-C, French Cooperative Group on Plasma Exchange in Guillain-Barré Syndrome. Early predictors of mechanical ventilation in Guillain-Barré syndrome. Crit Care Med 2003 31 1 278-283 (Pubitemid 36151185)
18. Garpestad E, Brennan J, Hill N S. Noninvasive ventilation for critical care. Chest 2007 132 2 711-720 (Pubitemid 47282412)
19. Pearse R M., Draper A, Grounds R M. Non-invasive ventilation to avoid tracheal intubation in a patient with Guillain-Barré syndrome. Br J Anaesth 2003 91 6 913-916 (Pubitemid 37508838)
20. Rabinstein A, Wijdicks E FM. BiPAP in acute respiratory failure due to myasthenic crisis may prevent intubation. Neurology 2002 59 10 1647-1649 (Pubitemid 35387080)
21. Seneviratne J, Mandrekar J, Wijdicks E FM, Rabinstein A A. Noninvasive ventilation in myasthenic crisis. Arch Neurol 2008 65 1 54-58
22. Wijdicks E FM, Roy T K. BiPAP in early Guillain-Barré syndrome may fail. Can J Neurol Sci 2006 33 1 105-106
23. Allolio B, Stuttmann R, Leonhard U, Fischer H, Winkelmann W. Adrenocortical suppression by a single induction dose of etomidate. Klin Wochenschr 1984 62 21 1014-1017 (Pubitemid 14017347)
24. Sprung C L., Annane D, Keh D et al, CORTICUS Study Group. Hydrocortisone therapy for patients with septic shock. N Engl J Med 2008 358 2 111-124
25. Bloomfield R, Noble D W. Etomidate, pharmacological adrenalectomy and the critically ill: a matter of vital importance. Crit Care 2006 10 4 161
26. Craven R. Ketamine. Anaesthesia 2007 62 Suppl 1 48-53 (Pubitemid 47610603)
27. Morris C, Perris A, Klein J, Mahoney P. Anaesthesia in haemodynamically compromised emergency patients: does ketamine represent the best choice of induction agent? Anaesthesia 2009 64 5 532-539
28. Reilly M, Hutchinson M. Suxamethonium is contraindicated in the Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry 1991 54 11 1018-1019
29. Eisenkraft J B., Book W J., Mann S M., Papatestas A E., Hubbard M. Resistance to succinylcholine in myasthenia gravis: a dose-response study. Anesthesiology 1988 69 5 760-763 (Pubitemid 18267678)
30. Baraka A, Baroody M, Yazbeck V. Repeated doses of suxamethonium in the myasthenic patient. Anaesthesia 1993 48 9 782-784 (Pubitemid 23268725)
31. Murthy J M., Meena A K., Chowdary G V., Naryanan J T. Myasthenic crisis: clinical features, complications and mortality. Neurol India 2005 53 1 37-40 discussion 40 (Pubitemid 40545192)
32. Thomas C E., Mayer S A., Gungor Y et al. Myasthenic crisis: clinical features, mortality, complications, and risk factors for prolonged intubation. Neurology 1997 48 5 1253-1260 (Pubitemid 27240543)
33. Lawn N D., Wijdicks E FM. Post-intubation pulmonary function test in Guillain-Barré syndrome. Muscle Nerve 2000 23 4 613-616 (Pubitemid 30164788)
34. Ali M I., Fernández-Pérez E R., Pendem S, Brown D R., Wijdicks E F., Gajic O. Mechanical ventilation in patients with Guillain-Barré syndrome. Respir Care 2006 51 12 1403-1407
35. Rabinstein A A., Mueller-Kronast N. Risk of extubation failure in patients with myasthenic crisis. Neurocrit Care 2005 3 3 213-215 (Pubitemid 43004813)
36. Gajdos P, Chevret S, Toyka K. Plasma exchange for myasthenia gravis. Cochrane Database Syst Rev 2002 4 CD002275 doi:10.1002/14651858.CD002275
37. Raphaël J-C, Chevret S, Hughes R AC, Annane D. Plasma exchange for Guillain-Barré syndrome. Cochrane Database Syst Rev 2002 2 CD001798 doi:10.1002/14651858.CD001798
38. Hughes R AC, Swan A V., van Doorn P A. Intravenous immunoglobulin for Guillain-Barré syndrome. Cochrane Database Syst Rev 2010 6 CD002063 doi:10.1002/14651858.CD002063.pub
39. Gajdos P, Chevret S, Toyka K V. Intravenous immunoglobulin for myasthenia gravis. Cochrane Database Syst Rev 2008 1 CD002277 doi:10.1002/14651858. CD002277.pub3 (Pubitemid 351807597)
40. Hughes R AC, Swan A V., van Doorn P A. Corticosteroids for Guillain-Barré syndrome. Cochrane Database Syst Rev 2010 2 CD001446 doi:10.1002/14651858.CD001446.pub3
41. Schneider-Gold C, Gajdos P, Toyka K V., Hohlfeld R R. Corticosteroids for myasthenia gravis. Cochrane Database Syst Rev 2005 2 CD002828 doi:10.1002/14651858.CD002828.pub2
42. Angelini C. Diagnosis and management of autoimmune myasthenia gravis. Clin Drug Investig 2011 31 1 1-14
43. Hadden R DM, Karch H, Hartung H-P et al, Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group. Preceding infections, immune factors, and outcome in Guillain-Barré syndrome. Neurology 2001 56 6 758-765 (Pubitemid 32240096)
44. Varelas P N., Chua H C., Natterman J et al. Ventilatory care in myasthenia gravis crisis: assessing the baseline adverse event rate. Crit Care Med 2002 30 12 2663-2668 (Pubitemid 36870567)
45. Seneviratne J, Mandrekar J, Wijdicks E FM, Rabinstein A A. Predictors of extubation failure in myasthenic crisis. Arch Neurol 2008 65 7 929-933 (Pubitemid 352008477)
46. Mayer S A. Intensive care of the myasthenic patient. Neurology 1997 48 S70-S75 (Pubitemid 27174924)
47. Mannam P, Siegel M D. Analytic review: management of life-threatening asthma in adults. J Intensive Care Med 2010 25 1 3-15
48. Rodriguez-Roisin R. Acute severe asthma: pathophysiology and pathobiology of gas exchange abnormalities. Eur Respir J 1997 10 6 1359-1371 (Pubitemid 27278262)
49. Rodrigo G J., Rodrigo C, Hall J B. Acute asthma in adults: a review. Chest 2004 125 3 1081-1102 (Pubitemid 38367305)
50. Papiris S, Kotanidou A, Malagari K, Roussos C. Clinical review: severe asthma. Crit Care 2002 6 1 30-44 (Pubitemid 34162856)
51. National Heart, Lung, and Blood Institute. Morbidity and mortality: 2010 chart book on cardiovascular, lung and blood diseases. http://www.nhlbi.nih.gov/ about/factbook/chapter4.htm Accessed September 3, 2011
52. Salmeron S, Liard R, Elkharrat D, Muir J, Neukirch F, Ellrodt A. Asthma severity and adequacy of management in accident and emergency departments in France: a prospective study. Lancet 2001 358 9282 629-635 (Pubitemid 32786828)
53. Pendergraft T B., Stanford R H., Beasley R, Stempel D A., Roberts C, McLaughlin T. Rates and characteristics of intensive care unit admissions and intubations among asthma-related hospitalizations. Ann Allergy Asthma Immunol 2004 93 1 29-35 (Pubitemid 39243133)
54. British Thoracic Society Scottish Intercollegiate Guidelines Network. British guideline on the management of asthma. Thorax 2008 63 Suppl 4 iv1-121 No abstract available
55. Holley A D., Boots R J. Review article: management of acute severe and near-fatal asthma. Emerg Med Australas 2009 21 4 259-268
56. Travers A, Jones A P., Kelly K, Barker S J., Camargo C A., Rowe B H. Intravenous beta2-agonists for acute asthma in the emergency department. Cochrane Database Syst Rev 2001 2 CD002988 doi.10.1002/14651858.CD002988
57. Abroug F, Nouira S, Bchir A, Boujdaria R, Elatrous S, Bouchoucha S. A controlled trial of nebulized salbutamol and adrenaline in acute severe asthma. Intensive Care Med 1995 21 1 18-23
58. Stoodley R G., Aaron S D., Dales R E. The role of ipratropium bromide in the emergency management of acute asthma exacerbation: a metaanalysis of randomized clinical trials. Ann Emerg Med 1999 34 1 8-18 (Pubitemid 29295746)
59. Rowe B H., Spooner C, Ducharme F M., Bretzlaff J A., Bota G W. Early emergency department treatment of acute asthma with systemic corticosteroids. Cochrane Database Syst Rev 2001 1 CD002178 doi:10.1002/14651858.CD002178
60. Rowe B H., Bretzlaff J A., Bourdon C, Bota G W., Camargo C A. Jr. Magnesium sulfate for treating exacerbations of acute asthma in the emergency department. Cochrane Database Syst Rev 2000 2 CD001490 doi:10.1002/14651858. CD001490
61. Parameswaran K, Belda J, Rowe B H. Addition of intravenous aminophylline to beta2-agonists in adults with acute asthma. Cochrane Database Syst Rev 2000 4 CD002742 doi:10.1002/14651858.CD002742
62. Camargo C A. Jr, Gurner D M., Smithline H A. et al. A randomized placebo-controlled study of intravenous montelukast for the treatment of acute asthma. J Allergy Clin Immunol 2010 125 2 374-380
63. Silverman R A., Nowak R M., Korenblat P E. et al. Zafirlukast treatment for acute asthma: evaluation in a randomized, double-blind, multicenter trial. Chest 2004 126 5 1480-1489 (Pubitemid 39525020)
64. Hess D R., Fink J B., Venkataraman S T., Kim I K., Myers T R., Tano B D. The history and physics of heliox. Respir Care 2006 51 6 608-612 (Pubitemid 46888372)
65. Rodrigo G, Pollack C, Rodrigo C, Rowe B H. Heliox for nonintubated acute asthma patients. Cochrane Database Syst Rev 2006 4 CD002884 doi:10.1002/ 14651858.CD002884.pub2
66. Wigmore T, Stachowski E. A review of the use of heliox in the critically ill. Crit Care Resusc 2006 8 1 64-72
67. Soroksky A, Stav D, Shpirer I. A pilot prospective, randomized, placebo-controlled trial of bilevel positive airway pressure in acute asthmatic attack. Chest 2003 123 4 1018-1025 (Pubitemid 36444356)
68. Ram F S., Wellington S, Rowe B H., Wedzicha J A. Non-invasive positive pressure ventilation for treatment of respiratory failure due to severe acute exacerbations of asthma. Cochrane Database Syst Rev 2005 1 CD004360
69. Brenner B, Corbridge T, Kazzi A. Intubation and mechanical ventilation of the asthmatic patient in respiratory failure. Proc Am Thorac Soc 2009 6 4 371-379
70. McCourt K C., Salmela L, Mirakhur R K. et al. Comparison of rocuronium and suxamethonium for use during rapid sequence induction of anaesthesia. Anaesthesia 1998 53 9 867-871 (Pubitemid 28431593)
71. Hogg R MG, Lappin E, Shields M O. et al. Sugammadex allows the use of rocuronium in place of succinylcholine during rapid sequence induction of anaesthesia. Br J Anaesth 2010 105 726P-727P
72. Phipps P, Garrard C S. The pulmonary physician in critical care. 12: acute severe asthma in the intensive care unit. Thorax 2003 58 1 81-88 (Pubitemid 36135364)
73. Stather D R., Stewart T E. Clinical review: mechanical ventilation in severe asthma. Crit Care 2005 9 6 581-587 (Pubitemid 43174467)
74. Hemmingsen C, Nielsen P K., Odorico J. Ketamine in the treatment of bronchospasm during mechanical ventilation. Am J Emerg Med 1994 12 4 417-420 (Pubitemid 24215775)
75. Sarma V J. Use of ketamine in acute severe asthma. Acta Anaesthesiol Scand 1992 36 1 106-107
76. Saulnier F F., Durocher A V., Deturck R A., Lefèbvre M C., Wattel F E. Respiratory and hemodynamic effects of halothane in status asthmaticus. Intensive Care Med 1990 16 2 104-107 (Pubitemid 20277722)
77. Maltais F, Sovilj M, Goldberg P, Gottfried S B. Respiratory mechanics in status asthmaticus. Effects of inhalational anesthesia. Chest 1994 106 5 1401-1406 (Pubitemid 24346099)
78. Elliot S C., Paramasivam K, Oram J, Bodenham A R., Howell S J., Mallick A. Pumpless extracorporeal carbon dioxide removal for life-threatening asthma. Crit Care Med 2007 35 3 945-948 (Pubitemid 46407815)
79. Marquette C H., Saulnier F, Leroy O et al. Long-term prognosis of near-fatal asthma. A 6-year follow-up study of 145 asthmatic patients who underwent mechanical ventilation for a near-fatal attack of asthma. Am Rev Respir Dis 1992 146 1 76-81
80. Barnes P J. Mechanisms in COPD: differences from asthma. Chest 2000 117 2, Suppl 10S-14S (Pubitemid 30111557)
81. Bleecker E R. Similarities and differences in asthma and COPD. The Dutch hypothesis. Chest 2004 126 2, Suppl 93S-95S discussion 159S-161S (Pubitemid 39093397)
82. Ali N K. Evidence-based approach to acute exacerbations of chronic obstructive pulmonary disease. Hosp Physician 2009 45 9-17 Available at: http://www.turner-white.com/cgi-bin/hmain2.cgi The article can be accessed at http://www.turner-white.com/memberfile.php?PubCode=hp-feb09-pulmonary.pdf
83. Turato G, Zuin R, Saetta M. Pathogenesis and pathology of COPD. Respiration 2001 68 2 117-128 (Pubitemid 32260861)
84. Davidson A C. The pulmonary physician in critical care. 11: critical care management of respiratory failure resulting from COPD. Thorax 2002 57 12 1079-1084 (Pubitemid 35440770)
85. Halbert R J., Natoli J L., Gano A, Badamgarav E, Buist A S., Mannino D M. Global burden of COPD: systematic review and meta-analysis. Eur Respir J 2006 28 3 523-532 (Pubitemid 44794666)
86. Seneff M G., Wagner D P., Wagner R P., Zimmerman J E., Knaus W A. Hospital and 1-year survival of patients admitted to intensive care units with acute exacerbation of chronic obstructive pulmonary disease. JAMA 1995 274 23 1852-1857 (Pubitemid 26001261)
87. Centers for Disease Control and Prevention. Deaths from chronic obstructive pulmonary diseaseUnited States, 20002005. MMWR Morb Mortal Wkly Rep 2008 57 45 1229-1232 http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5745a4.htm
88. MacIntyre N, Huang Y C. Acute exacerbations and respiratory failure in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2008 5 4 530-535 (Pubitemid 351669182)
89. O'Driscoll B R., Howard L S., Davison A G., British Thoracic Society. BTS guideline for emergency oxygen use in adult patients. Thorax 2008 63 Suppl 6 vi1-vi68
90. Hanson C WI III, Marshall B E., Frasch H F., Marshall C. Causes of hypercarbia with oxygen therapy in patients with chronic obstructive pulmonary disease. Crit Care Med 1996 24 1 23-28
91. Karpel J P. Bronchodilator responses to anticholinergic and beta-adrenergic agents in acute and stable COPD. Chest 1991 99 4 871-876
92. Bach P B., Brown C, Gelfand S E., McCrory D C., American College of Physicians-American Society of Internal Medicine American College of Chest Physicians. Management of acute exacerbations of chronic obstructive pulmonary disease: a summary and appraisal of published evidence. Ann Intern Med 2001 134 7 600-620 (Pubitemid 32245323)
93. Gross N J. Anticholinergic agents in asthma and COPD. Eur J Pharmacol 2006 533 1-3 36-39 (Pubitemid 43340003)
94. Walters J A., Gibson P G., Wood-Baker R, Hannay M, Walters E H. Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2009 1 CD001288
95. Nouira S, Marghli S, Belghith M, Besbes L, Elatrous S, Abroug F. Once daily oral ofloxacin in chronic obstructive pulmonary disease exacerbation requiring mechanical ventilation: a randomised placebo-controlled trial. Lancet 2001 358 9298 2020-2025 (Pubitemid 34084824)
96. National Clinical Guideline Centre. Chronic obstructive pulmonary disease: management of chronic obstructive pulmonary disease in adults in primary and secondary care. London National Clinical Guideline Centre. 2010 http://guidance.nice.org.uk/CG101
97. Barr R G., Rowe B H., Camargo C A. Jr. Methylxanthines for exacerbations of chronic obstructive pulmonary disease: meta-analysis of randomised trials. BMJ 2003 327 7416 643
98. Ram F S., Picot J, Lightowler J, Wedzicha J A. Non-invasive positive pressure ventilation for treatment of respiratory failure due to exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2004 3 CD004104 doi:10.1002/14651858.CD004104.pub3
99. Moretti M, Cilione C, Tampieri A, Fracchia C, Marchioni A, Nava S. Incidence and causes of non-invasive mechanical ventilation failure after initial success. Thorax 2000 55 10 819-825
100. Girault C, Daudenthun I, Chevron V, Tamion F, Leroy J, Bonmarchand G. Noninvasive ventilation as a systematic extubation and weaning technique in acute-on-chronic respiratory failure: a prospective, randomized controlled study. Am J Respir Crit Care Med 1999 160 1 86-92 (Pubitemid 29326072)
101. Esteban A, Anzueto A, Frutos F et al, Mechanical Ventilation International Study Group. Characteristics and outcomes in adult patients receiving mechanical ventilation: a 28-day international study. JAMA 2002 287 3 345-355 (Pubitemid 34251968)
102. Huiart L, Ernst P, Suissa S. Cardiovascular morbidity and mortality in COPD. Chest 2005 128 4 2640-2646 (Pubitemid 41507622)
103. Salpeter S R., Buckley N S., Salpeter E E. Meta-analysis: anticholinergics, but not -agonists, reduce severe exacerbations and respiratory mortality in COPD. J Gen Intern Med 2006 21 10 1011-1019 (Pubitemid 44337728)
104. Salpeter S R., Buckley N S., Ormiston T M., Salpeter E E. Meta-analysis: effect of long-acting -agonists on severe asthma exacerbations and asthma-related deaths. Ann Intern Med 2006 144 12 904-912 (Pubitemid 46768131)
105. Noveanu M, Breidthardt T, Reichlin T et al. Effect of oral beta-blocker on short and long-term mortality in patients with acute respiratory failure: results from the BASEL-II-ICU study. Crit Care 2010 14 6 R198
106. Ware L B. Pathophysiology of acute lung injury and the acute respiratory distress syndrome. Semin Respir Crit Care Med 2006 27 4 337-349 (Pubitemid 44272603)
107. Ashbaugh D G., Bigelow D B., Petty T L., Levine B E. Acute respiratory distress in adults. Lancet 1967 2 7511 319-323
108. Rubenfeld G D., Caldwell E, Peabody E et al. Incidence and outcomes of acute lung injury. N Engl J Med 2005 353 16 1685-1693 (Pubitemid 41464707)
109. Papazian L, Forel J-M, Gacouin A et al, ACURASYS Study Investigators. Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med 2010 363 12 1107-1116
110. Zambon M, Vincent J-L. Mortality rates for patients with acute lung injury/ARDS have decreased over time. Chest 2008 133 5 1120-1127 (Pubitemid 351685515)
111. Wheeler A P., Bernard G R., Thompson B T. et al, National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network. Pulmonary-artery versus central venous catheter to guide treatment of acute lung injury. N Engl J Med 2006 354 21 2213-2224 (Pubitemid 43788136)
112. Gattinoni L, Pelosi P, Suter P M., Pedoto A, Vercesi P, Lissoni A. Acute respiratory distress syndrome caused by pulmonary and extrapulmonary disease. Different syndromes? Am J Respir Crit Care Med 1998 158 1 3-11 (Pubitemid 28337150)
113. Atabai K, Matthay M A. The pulmonary physician in critical care, V: Acute lung injury and the acute respiratory distress syndrome: definitions and epidemiology. Thorax 2002 57 5 452-458 (Pubitemid 34494160)
114. Flores C, Pino-Yanes M M., Casula M, Villar J. Genetics of acute lung injury: past, present and future. Minerva Anestesiol 2010 76 10 860-864
115. Bellingan G J. The pulmonary physician in critical care * 6: the pathogenesis of ALI/ARDS. Thorax 2002 57 6 540-546 (Pubitemid 34627988)
116. Bernard G R., Artigas A, Brigham K L. et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994 149 3 Pt 1 818-824 (Pubitemid 24082248)
117. Abraham E, Matthay M A., Dinarello C A. et al. Consensus conference definitions for sepsis, septic shock, acute lung injury, and acute respiratory distress syndrome: time for a reevaluation. Crit Care Med 2000 28 1 232-235 (Pubitemid 30091059)
118. Villar J, Pérez-Méndez L, Kacmarek R M. Current definitions of acute lung injury and the acute respiratory distress syndrome do not reflect their true severity and outcome. Intensive Care Med 1999 25 9 930-935 (Pubitemid 29452537)
119. Rubenfeld G D., Caldwell E, Granton J, Hudson L D., Matthay M A. Interobserver variability in applying a radiographic definition for ARDS. Chest 1999 116 5 1347-1353 (Pubitemid 29535991)
120. Ferguson N D., Meade M O., Hallett D C., Stewart T E. High values of the pulmonary artery wedge pressure in patients with acute lung injury and acute respiratory distress syndrome. Intensive Care Med 2002 28 8 1073-1077 (Pubitemid 34985229)
121. Iberti T J., Fischer E P., Leibowitz A B., Panacek E A., Silverstein J H., Albertson T E., Pulmonary Artery Catheter Study Group. A multicenter study of physicians' knowledge of the pulmonary artery catheter. JAMA 1990 264 22 2928-2932
122. Iberti T J., Daily E K., Leibowitz A B., Schecter C B., Fischer E P., Silverstein J H., The Pulmonary Artery Catheter Study Group. Assessment of critical care nurses' knowledge of the pulmonary artery catheter. Crit Care Med 1994 22 10 1674-1678 (Pubitemid 24320893)
123. Esteban A, Fernández-Segoviano P, Frutos-Vivar F et al. Comparison of clinical criteria for the acute respiratory distress syndrome with autopsy findings. Ann Intern Med 2004 141 6 440-445
124. Tzouvelekis A, Pneumatikos I, Bouros D. Serum biomarkers in acute respiratory distress syndrome an ailing prognosticator. Respir Res 2005 6 62
125. Nuckton T J., Alonso J A., Kallet R H. et al. Pulmonary dead-space fraction as a risk factor for death in the acute respiratory distress syndrome. N Engl J Med 2002 346 17 1281-1286 (Pubitemid 34429459)
126. Agarwal R, Aggarwal A N., Gupta D. Role of noninvasive ventilation in acute lung injury/acute respiratory distress syndrome: a proportion meta-analysis. Respir Care 2010 55 12 1653-1660
127. Ortiz G, Frutos-Vivar F, Ferguson N D. et al, Ventila Group. Outcomes of patients ventilated with synchronized intermittent mandatory ventilation with pressure support: a comparative propensity score study. Chest 2010 137 6 1265-1277
128. Rodriguez P, Michel D, Brochard L. Mechanical ventilation: changing concepts. Indian J Crit Care Med 2005 9 235-243 (Pubitemid 43269319)
129. Davis K Jr, Branson R D., Campbell R S., Porembka D T. Comparison of volume control and pressure control ventilation: is flow waveform the difference? J Trauma 1996 41 5 808-814 (Pubitemid 26403375)
130. Piotrowski A, Sobala W, Kawczyski P. Patient-initiated, pressure-regulated, volume-controlled ventilation compared with intermittent mandatory ventilation in neonates: a prospective, randomised study. Intensive Care Med 1997 23 9 975-981 (Pubitemid 27464706)
131. Amato M B., Barbas C S., Bonassa J, Saldiva P H., Zin W A., de Carvalho C R. Volume-assured pressure support ventilation (VAPSV): a new approach for reducing muscle workload during acute respiratory failure. Chest 1992 102 4 1225-1234
132. Stock M C., Downs J B., Frolicher D A. Airway pressure release ventilation. Crit Care Med 1987 15 5 462-466 (Pubitemid 17080297)
133. Sinderby C, Navalesi P, Beck J et al. Neural control of mechanical ventilation in respiratory failure. Nat Med 1999 5 12 1433-1436
134. Younes M, Puddy A, Roberts D et al. Proportional assist ventilation: results of an initial clinical trial. Am Rev Respir Dis 1992 145 1 121-129
135. Webb H H., Tierney D F. Experimental pulmonary edema due to intermittent positive pressure ventilation with high inflation pressures: protection by positive end-expiratory pressure. Am Rev Respir Dis 1974 110 5 556-565
136. Tremblay L, Valenza F, Ribeiro S P., Li J, Slutsky A S. Injurious ventilatory strategies increase cytokines and c-fos m-RNA expression in an isolated rat lung model. J Clin Invest 1997 99 5 944-952 (Pubitemid 27123631)
137. Dreyfuss D, Soler P, Basset G, Saumon G. High inflation pressure pulmonary edema: respective effects of high airway pressure, high tidal volume, and positive end-expiratory pressure. Am Rev Respir Dis 1988 137 5 1159-1164
138. Slutsky A S. Lung injury caused by mechanical ventilation. Chest 1999 116 1, Suppl 9S-15S (Pubitemid 29340179)
139. Tremblay L N., Slutsky A S. Ventilator-induced injury: from barotrauma to biotrauma. Proc Assoc Am Physicians 1998 110 6 482-488 (Pubitemid 28516123)
140. Levine S, Nguyen T, Taylor N et al. Rapid disuse atrophy of diaphragm fibers in mechanically ventilated humans. N Engl J Med 2008 358 13 1327-1335 (Pubitemid 351468409)
141. Register S D., Downs J B., Stock M C., Kirby R R. Is 50% oxygen harmful? Crit Care Med 1987 15 6 598-601
142. Hedenstierna G, Rothen H U. Atelectasis formation during anesthesia: causes and measures to prevent it. J Clin Monit Comput 2000 16 5-6 329-335 (Pubitemid 32529687)
143. Gattinoni L, Pesenti A. ARDS: the nonhomogeneous lung; facts and hypothesis. Intensive Crit Care Dig 1987 6 1-4
144. The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000 342 18 1301-1308
145. Hager D N., Krishnan J A., Hayden D L., Brower R G., ARDS Clinical Trials Network. Tidal volume reduction in patients with acute lung injury when plateau pressures are not high. Am J Respir Crit Care Med 2005 172 10 1241-1245 (Pubitemid 43076561)
146. Rimensberger P C., Cox P N., Frndova H, Bryan A C. The open lung during small tidal volume ventilation: concepts of recruitment and optimal positive end-expiratory pressure. Crit Care Med 1999 27 9 1946-1952 (Pubitemid 29455129)
147. Putensen C, Theuerkauf N, Zinserling J, Wrigge H, Pelosi P. Meta-analysis: ventilation strategies and outcomes of the acute respiratory distress syndrome and acute lung injury. Ann Intern Med 2009 151 8 566-576
148. Steinberg K P., Kacmarek R M. Respiratory controversies in the critical care setting. Should tidal volume be 6 mL/kg predicted body weight in virtually all patients with acute respiratory failure? Respir Care 2007 52 5 556-564 discussion 565-567
149. Determann R M., Royakkers A, Wolthuis E K. et al. Ventilation with lower tidal volumes as compared with conventional tidal volumes for patients without acute lung injury: a preventive randomized controlled trial. Crit Care 2010 14 1 R1
150. Drakulovic M B., Torres A, Bauer T T., Nicolas J M., Nogué S, Ferrer M. Supine body position as a risk factor for nosocomial pneumonia in mechanically ventilated patients: a randomised trial. Lancet 1999 354 9193 1851-1858
151. Kress J P., Pohlman A S., O'Connor M F., Hall J B. Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. N Engl J Med 2000 342 20 1471-1477 (Pubitemid 30318270)
152. Esteban A, Frutos F, Tobin M J. et al, Spanish Lung Failure Collaborative Group. A comparison of four methods of weaning patients from mechanical ventilation. N Engl J Med 1995 332 6 345-350
153. Hall R I., Sandham D, Cardinal P et al, Study Investigators. Propofol vs midazolam for ICU sedation: a Canadian multicenter randomized trial. Chest 2001 119 4 1151-1159 (Pubitemid 32679444)
154. Meade M, Guyatt G, Cook D et al. Predicting success in weaning from mechanical ventilation. Chest 2001 120 6, Suppl 400S-424S (Pubitemid 34015782)
155. Yang K L., Tobin M J. A prospective study of indexes predicting the outcome of trials of weaning from mechanical ventilation. N Engl J Med 1991 324 21 1445-1450
156. O'Croinin D, Ni Chonghaile M, Higgins B, Laffey J G. Bench-to-bedside review: permissive hypercapnia. Crit Care 2005 9 1 51-59 (Pubitemid 40246771)
157. Armstrong B WJ Jr, MacIntyre N R. Pressure-controlled, inverse ratio ventilation that avoids air trapping in the adult respiratory distress syndrome. Crit Care Med 1995 23 2 279-285
158. Pelosi P, Brazzi L, Gattinoni L. Prone position in acute respiratory distress syndrome. Eur Respir J 2002 20 4 1017-1028 (Pubitemid 35175144)
159. Fan E, Wilcox M E., Brower R G. et al. Recruitment maneuvers for acute lung injury: a systematic review. Am J Respir Crit Care Med 2008 178 11 1156-1163
160. Sud S, Sud M, Friedrich J O., Adhikari N KJ. Effect of mechanical ventilation in the prone position on clinical outcomes in patients with acute hypoxemic respiratory failure: a systematic review and meta-analysis. CMAJ 2008 178 9 1153-1161 (Pubitemid 351580074)
161. Gattinoni L, Carlesso E, Taccone P, Polli F, Guérin C, Mancebo J. Prone positioning improves survival in severe ARDS: a pathophysiologic review and individual patient meta-analysis. Minerva Anestesiol 2010 76 6 448-454
162. Hess D R., Gillette M A. Tracheal gas insufflation and related techniques to introduce gas flow into the trachea. Respir Care 2001 46 2 119-129 (Pubitemid 33759346)
163. Goldhill D R., Imhoff M, McLean B, Waldmann C. Rotational bed therapy to prevent and treat respiratory complications: a review and meta-analysis. Am J Crit Care 2007 16 1 50-61 quiz 62
164. Wiedemann H P., Wheeler A P., Bernard G R. et al, National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network. Comparison of two fluid-management strategies in acute lung injury. N Engl J Med 2006 354 24 2564-2575 (Pubitemid 43882352)
165. Humphrey H, Hall J, Sznajder I, Silverstein M, Wood L. Improved survival in ARDS patients associated with a reduction in pulmonary capillary wedge pressure. Chest 1990 97 5 1176-1180 (Pubitemid 20166812)
166. Sakr Y, Vincent J-L, Reinhart K et al, Sepsis Occurence in Acutely Ill Patients Investigators. High tidal volume and positive fluid balance are associated with worse outcome in acute lung injury. Chest 2005 128 5 3098-3108 (Pubitemid 41698628)
167. Afshari A, Brok J, Møller A M., Wetterslev J. Inhaled nitric oxide for acute respiratory distress syndrome and acute lung injury in adults and children: a systematic review with meta-analysis and trial sequential analysis. Anesth Analg 2011 112 6 1411-1421
168. Abraham E, Park Y C., Covington P, Conrad S A., Schwartz M. Liposomal prostaglandin E1 in acute respiratory distress syndrome: a placebo-controlled, randomized, double-blind, multicenter clinical trial. Crit Care Med 1996 24 1 10-15
169. Reyes A, Roca J, Rodriguez-Roisin R, Torres A, Ussetti P, Wagner P D. Effect of almitrine on ventilation-perfusion distribution in adult respiratory distress syndrome. Am Rev Respir Dis 1988 137 5 1062-1067
170. Gallart L, Lu Q IN, Puybasset L, Umamaheswara Rao G S., Coriat P, Rouby J J., The NO Almitrine Study Group. Intravenous almitrine combined with inhaled nitric oxide for acute respiratory distress syndrome. Am J Respir Crit Care Med 1998 158 6 1770-1777 (Pubitemid 29008813)
171. Liu K D., Levitt J, Zhuo H et al. Randomized clinical trial of activated protein C for the treatment of acute lung injury. Am J Respir Crit Care Med 2008 178 6 618-623
172. Adhikari N KJ, Scales D C. Corticosteroids for acute respiratory distress syndrome. BMJ 2008 336 7651 969-970 (Pubitemid 351656067)
173. The ARDS Network. Ketoconazole for early treatment of acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. JAMA 2000 283 15 1995-2002
174. Montravers P, Fagon J Y., Gilbert C, Blanchet F, Novara A, Chastre J. Pilot study of cardiopulmonary risk from pentoxifylline in adult respiratory distress syndrome. Chest 1993 103 4 1017-1022 (Pubitemid 23110263)
175. The Acute Respiratory Disease Syndrome Network. Randomized, placebo-controlled trial of lisofylline for early treatment of acute lung injury and acute respiratory distress syndrome. Crit Care Med 2002 30 1 1-6
176. Raoof S, Goulet K, Esan A, Hess D R., Sessler C N. Severe hypoxemic respiratory failure, II: Nonventilatory strategies. Chest 2010 137 6 1437-1448
177. Spragg R G., Lewis J F., Wurst W et al. Treatment of acute respiratory distress syndrome with recombinant surfactant protein C surfactant. Am J Respir Crit Care Med 2003 167 11 1562-1566 (Pubitemid 37363368)
178. Matthay M A., Brower R, Thompson B T. et al. Randomized, placebo controlled trial of an aerosolized beta-2 adrenergic agonist (albuterol) for the treatment of acute lung injury. Am J Respir Crit Care Med 2009 179 A2166
179. Meduri G U., Golden E, Freire A X. et al. Methylprednisolone infusion in early severe ARDS: results of a randomized controlled trial. Chest 2007 131 4 954-963 (Pubitemid 46608692)
180. Peter J V., John P, Graham P L., Moran J L., George I A., Bersten A. Corticosteroids in the prevention and treatment of acute respiratory distress syndrome (ARDS) in adults: meta-analysis. BMJ 2008 336 7651 1006-1009 (Pubitemid 351656093)
181. Matthay M A., Thompson B T., Read E J. et al. Therapeutic potential of mesenchymal stem cells for severe acute lung injury. Chest 2010 138 4 965-972
182. Ware L B., Matthay M A. Keratinocyte and hepatocyte growth factors in the lung: roles in lung development, inflammation, and repair. Am J Physiol Lung Cell Mol Physiol 2002 282 5 L924-L940 (Pubitemid 34654608)
183. Downar J, Mehta S. Bench-to-bedside review: high-frequency oscillatory ventilation in adults with acute respiratory distress syndrome. Crit Care 2006 10 6 240
184. Chan K PW, Stewart T E., Mehta S. High-frequency oscillatory ventilation for adult patients with ARDS. Chest 2007 131 6 1907-1916 (Pubitemid 46981653)
185. Sud S, Sud M, Friedrich J O. et al. High frequency oscillation in patients with acute lung injury and acute respiratory distress syndrome (ARDS): systematic review and meta-analysis. BMJ 2010 340 c2327
186. Kaisers U, Kelly K P., Busch T. Liquid ventilation. Br J Anaesth 2003 91 1 143-151 (Pubitemid 36857323)
187. Kacmarek R M., Wiedemann H P., Lavin P T., Wedel M K., Tütüncü A S., Slutsky A S. Partial liquid ventilation in adult patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 2006 173 8 882-889
188. Davies A, Jones D, Bailey M et al, Australia and New Zealand Extracorporeal Membrane Oxygenation (ANZ ECMO) Influenza Investigators. Extracorporeal membrane oxygenation for 2009 influenza A(H1N1) acute respiratory distress syndrome. JAMA 2009 302 17 1888-1895
189. Matheis G. New technologies for respiratory assist. Perfusion 2003 18 4 245-251 (Pubitemid 37259410)
190. Zapol W M., Snider M T., Hill J D. et al. Extracorporeal membrane oxygenation in severe acute respiratory failure. A randomized prospective study. JAMA 1979 242 20 2193-2196 (Pubitemid 10195729)
191. Morris A H., Wallace C J., Menlove R L. et al. Randomized clinical trial of pressure-controlled inverse ratio ventilation and extracorporeal CO2 removal for adult respiratory distress syndrome. Am J Respir Crit Care Med 1994 149 2 Pt 1 295-305 Erratum appears in Am J Respir Crit Care Med 1994;149(3 Pt 1):838 (Pubitemid 24068971)
192. Zwischenberger J B., Lynch J E. Will CESAR answer the adult ECMO debate? Lancet 2009 374 9698 1307-1308
193. Peek G J., Mugford M, Tiruvoipati R et al, CESAR trial collaboration. Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet 2009 374 9698 1351-1363
194. Extracorporeal Life Support Organization. ELSO Registry Information. http://www.elso.med.umich.edu/Registry.html Accessed March 20, 2011
195. Stapleton R D., Wang B M., Hudson L D., Rubenfeld G D., Caldwell E S., Steinberg K P. Causes and timing of death in patients with ARDS. Chest 2005 128 2 525-532 (Pubitemid 41140476)
196. Montgomery A B., Stager M A., Carrico C J., Hudson L D. Causes of mortality in patients with the adult respiratory distress syndrome. Am Rev Respir Dis 1985 132 3 485-489 (Pubitemid 15247959)
197. Vincent J L., Sakr Y, Ranieri V M. Epidemiology and outcome of acute respiratory failure in intensive care unit patients. Crit Care Med 2003 31 4, Suppl S296-S299 (Pubitemid 36458182)
198. Cottrell T S., Levine O R., Senior R M., Wiener J, Spiro D, Fishman A P. Electron microscopic alterations at the alveolar level in pulmonary edema. Circ Res 1967 21 6 783-797
199. Ware L B., Matthay M A. Clinical practice. Acute pulmonary edema. N Engl J Med 2005 353 26 2788-2796 (Pubitemid 43016818)
200. Gehlbach B K., Geppert E. The pulmonary manifestations of left heart failure. Chest 2004 125 2 669-682 (Pubitemid 38223649)
201. Cleland J G., Yassin A S., Khadjooi K. Acute heart failure: focusing on acute cardiogenic pulmonary oedema. Clin Med 2010 10 1 59-64
202. Gheorghiade M, Pang P S. Acute heart failure syndromes. J Am Coll Cardiol 2009 53 7 557-573
203. Schappert S, Rechtsteiner E. Ambulatory Medical Care Utilization Estimates for 2006. National Health Statistics Reports. 2008. http://198.246.98.21/nchs/data/nhsr/nhsr008.pdf Accessed March 15, 2011
204. Gray A, Goodacre S, Newby D E., Masson M, Sampson F, Nicholl J, 3CPO Trialists. Noninvasive ventilation in acute cardiogenic pulmonary edema. N Engl J Med 2008 359 2 142-151 (Pubitemid 351962037)
205. Edoute Y, Roguin A, Behar D, Reisner S A. Prospective evaluation of pulmonary edema. Crit Care Med 2000 28 2 330-335 (Pubitemid 30120868)
206. Roguin A, Behar D M., Ben Ami H et al. Long-term prognosis of acute pulmonary oedemaan ominous outcome. Eur J Heart Fail 2000 2 2 137-144 (Pubitemid 30407553)
207. Drazner M H., Rame J E., Stevenson L W., Dries D L. Prognostic importance of elevated jugular venous pressure and a third heart sound in patients with heart failure. N Engl J Med 2001 345 8 574-581 (Pubitemid 32772099)
208. Gluecker T, Capasso P, Schnyder P et al. Clinical and radiologic features of pulmonary edema. Radiographics 1999 19 6 1507-1531 discussion 1532-1533
209. Aberle D R., Wiener-Kronish J P., Webb W R., Matthay M A. Hydrostatic versus increased permeability pulmonary edema: diagnosis based on radiographic criteria in critically ill patients. Radiology 1988 168 1 73-79
210. Collins S P., Lindsell C J., Storrow A B., Abraham W T., ADHERE Scientific Advisory Committee, Investigators and Study Group. Prevalence of negative chest radiography results in the emergency department patient with decompensated heart failure. Ann Emerg Med 2006 47 1 13-18 (Pubitemid 43011322)
211. Pistolesi M, Giuntini C. Assessment of extravascular lung water. Radiol Clin North Am 1978 16 3 551-574 (Pubitemid 9105583)
212. Worster A, Balion C M., Hill S A. et al. Diagnostic accuracy of BNP and NT-proBNP in patients presenting to acute care settings with dyspnea: a systematic review. Clin Biochem 2008 41 4-5 250-259 (Pubitemid 351249854)
213. Wang C S., FitzGerald J M., Schulzer M, Mak E, Ayas N T. Does this dyspneic patient in the emergency department have congestive heart failure? JAMA 2005 294 15 1944-1956 (Pubitemid 41464696)
214. Zimetbaum P J., Josephson M E. Use of the electrocardiogram in acute myocardial infarction. N Engl J Med 2003 348 10 933-940 (Pubitemid 36298001)
215. Price S, Nicol E, Gibson D G., Evans T W. Echocardiography in the critically ill: current and potential roles. Intensive Care Med 2006 32 1 48-59 (Pubitemid 43039376)
216. Copetti R, Soldati G, Copetti P. Chest sonography: a useful tool to differentiate acute cardiogenic pulmonary edema from acute respiratory distress syndrome. Cardiovasc Ultrasound 2008 6 16
217. Harvey S, Young D, Brampton W et al. Pulmonary artery catheters for adult patients in intensive care. Cochrane Database Syst Rev 2006 3 3 CD003408 doi:10.1002/14651858.CD003408.pub2
218. Ware L B., Fremont R D., Bastarache J A., Calfee C S., Matthay M A. Determining the aetiology of pulmonary oedema by the oedema fluid-to-plasma protein ratio. Eur Respir J 2010 35 2 331-337
219. Haque W A., Boehmer J, Clemson B S., Leuenberger U A., Silber D H., Sinoway L I. Hemodynamic effects of supplemental oxygen administration in congestive heart failure. J Am Coll Cardiol 1996 27 2 353-357 (Pubitemid 26046618)
220. Prinianakis G, Klimathianaki M, Georgopoulos D. Physiological rationale of noninvasive mechanical ventilation use in acute respiratory failure. Eur Respir Monogr 2008 41 3-23
221. Weng C-L, Zhao Y-T, Liu Q-H et al. Meta-analysis: noninvasive ventilation in acute cardiogenic pulmonary edema. Ann Intern Med 2010 152 9 590-600
222. Sosnowski M A. Review article: lack of effect of opiates in the treatment of acute cardiogenic pulmonary oedema. Emerg Med Australas 2008 20 5 384-390
223. Dickstein K, Cohen-Solal A, Filippatos G et al, ESC Committee for Practice Guidelines (CPG). ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail 2008 10 10 933-989 Corrected in Eur J Heart Fail 2010;12(4):416 (note: dosage error in article text)
224. Cotter G, Metzkor E, Kaluski E et al. Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema. Lancet 1998 351 9100 389-393 (Pubitemid 28064161)
225. Jhund P S., McMurray J JV, Davie A P. The acute vascular effects of frusemide in heart failure. Br J Clin Pharmacol 2000 50 1 9-13 (Pubitemid 30416964)
226. Singer M, Glynne P. Treating critical illness: the importance of first doing no harm. PLoS Med 2005 2 6 e167
227. Sackner-Bernstein J D., Kowalski M, Fox M, Aaronson K. Short-term risk of death after treatment with nesiritide for decompensated heart failure: a pooled analysis of randomized controlled trials. JAMA 2005 293 15 1900-1905 (Pubitemid 40548187)
228. Hamilton R J., Carter W A., Gallagher E J. Rapid improvement of acute pulmonary edema with sublingual captopril. Acad Emerg Med 1996 3 3 205-212 (Pubitemid 26153128)
229. Annane D, Bellissant E, Pussard E et al. Placebo-controlled, randomized, double-blind study of intravenous enalaprilat efficacy and safety in acute cardiogenic pulmonary edema. Circulation 1996 94 6 1316-1324 (Pubitemid 26307259)
230. Petersen J W., Felker G M. Inotropes in the management of acute heart failure. Crit Care Med 2008 36 1, Suppl S106-S111
231. Scheidt S, Wilner G, Mueller H et al. Intra-aortic balloon counterpulsation in cardiogenic shock. Report of a co-operative clinical trial. N Engl J Med 1973 288 19 979-984
232. Rose E A., Gelijns A C., Moskowitz A J. et al, Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) Study Group. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med 2001 345 20 1435-1443
233. Slaughter M S., Rogers J G., Milano C A. et al, HeartMate II Investigators. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med 2009 361 23 2241-2251
234. Combes A, Leprince P, Luyt C-E et al. Outcomes and long-term quality-of-life of patients supported by extracorporeal membrane oxygenation for refractory cardiogenic shock. Crit Care Med 2008 36 5 1404-1411 (Pubitemid 351620652)
235. Goldhaber S Z., Elliott C G. Acute pulmonary embolism: part I: epidemiology, pathophysiology, and diagnosis. Circulation 2003 108 22 2726-2729 (Pubitemid 37498971)
236. McIntyre K M., Sasahara A A. The hemodynamic response to pulmonary embolism in patients without prior cardiopulmonary disease. Am J Cardiol 1971 28 3 288-294
237. Smulders Y M. Pathophysiology and treatment of haemodynamic instability in acute pulmonary embolism: the pivotal role of pulmonary vasoconstriction. Cardiovasc Res 2000 48 1 23-33
238. Piazza G, Goldhaber S Z. Management of submassive pulmonary embolism. Circulation 2010 122 11 1124-1129
239. Kasper W, Geibel A, Tiede N, Just H. Patent foramen ovale in patients with haemodynamically significant pulmonary embolism. Lancet 1992 340 8819 561-564
240. Dalen J E., Alpert J S. Natural history of pulmonary embolism. Prog Cardiovasc Dis 1975 17 4 259-270
241. Torbicki A, Perrier A, Konstantinides S et al, ESC Committee for Practice Guidelines (CPG). Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Eur Heart J 2008 29 18 2276-2315
242. Goldhaber S Z., Visani L, De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet 1999 353 9162 1386-1389 (Pubitemid 29192409)
243. Kasper W, Konstantinides S, Geibel A et al. Management strategies and determinants of outcome in acute major pulmonary embolism: results of a multicenter registry. J Am Coll Cardiol 1997 30 5 1165-1171
244. Anderson F A. Jr, Spencer F A. Risk factors for venous thromboembolism. Circulation 2003 107 23, Suppl 1 I9-I16 (Pubitemid 41289266)
245. Kearon C. Natural history of venous thromboembolism. Circulation 2003 107 23, Suppl 1 I22-I30 (Pubitemid 41289268)
246. Wells P S., Anderson D R., Rodger M et al. Derivation of a simple clinical model to categorize patients probability of pulmonary embolism: increasing the models utility with the SimpliRED D-dimer. Thromb Haemost 2000 83 3 416-420 (Pubitemid 30148355)
247. Wicki J, Perneger T V., Junod A F., Bounameaux H, Perrier A. Assessing clinical probability of pulmonary embolism in the emergency ward: a simple score. Arch Intern Med 2001 161 1 92-97 (Pubitemid 32052148)
248. Le Gal G, Righini M, Roy P-M et al. Prediction of pulmonary embolism in the emergency department: the revised Geneva score. Ann Intern Med 2006 144 3 165-171 (Pubitemid 46780688)
249. Chunilal S D., Eikelboom J W., Attia J et al. Does this patient have pulmonary embolism? JAMA 2003 290 21 2849-2858 (Pubitemid 37509494)
250. Agnelli G, Becattini C. Acute pulmonary embolism. N Engl J Med 2010 363 3 266-274
251. Carlbom D J., Davidson B L. Pulmonary embolism in the critically ill. Chest 2007 132 1 313-324 (Pubitemid 47068237)
252. Goldhaber S Z. Echocardiography in the management of pulmonary embolism. Ann Intern Med 2002 136 9 691-700 (Pubitemid 34462682)
253. Chartier L, Béra J, Delomez M et al. Free-floating thrombi in the right heart: diagnosis, management, and prognostic indexes in 38 consecutive patients. Circulation 1999 99 21 2779-2783 (Pubitemid 29250024)
254. Ghaye B, Szapiro D, Mastora I et al. Peripheral pulmonary arteries: how far in the lung does multi-detector row spiral CT allow analysis? Radiology 2001 219 3 629-636 (Pubitemid 32476249)
255. Araoz P A., Gotway M B., Harrington J R., Harmsen W S., Mandrekar J N. Pulmonary embolism: prognostic CT findings. Radiology 2007 242 3 889-897
256. van der Meer R W., Pattynama P MT, van Strijen M JL et al. Right ventricular dysfunction and pulmonary obstruction index at helical CT: prediction of clinical outcome during 3-month follow-up in patients with acute pulmonary embolism. Radiology 2005 235 3 798-803 (Pubitemid 40695872)
257. Mercat A, Diehl J-L, Meyer G, Teboul J-L, Sors H. Hemodynamic effects of fluid loading in acute massive pulmonary embolism. Crit Care Med 1999 27 3 540-544 (Pubitemid 29162674)
258. Layish D T., Tapson V F. Pharmacologic hemodynamic support in massive pulmonary embolism. Chest 1997 111 1 218-224 (Pubitemid 27043633)
259. Bursztein S, Taitelman U, De Myttenaere S et al. Reduced oxygen consumption in catabolic states with mechanical ventilation. Crit Care Med 1978 6 3 162-164
260. Kress J P., O'Connor M F., Pohlman A S. et al. Sedation of critically ill patients during mechanical ventilation: a comparison of propofol and midazolam. Am J Respir Crit Care Med 1996 153 3 1012-1018
261. Spence T H., Newton W D. Pulmonary embolism: improvement in hemodynamic function with amrinone therapy. South Med J 1989 82 10 1267-1268 (Pubitemid 20015864)
262. Boulain T, Lanotte R, Legras A, Perrotin D. Efficacy of epinephrine therapy in shock complicating pulmonary embolism. Chest 1993 104 1 300-302 (Pubitemid 23204581)
263. McDonald I G., Hirsh J, Hale G S., Cade J F., McCarthy R A. Isoproterenol in massive pulmonary embolism: haemodynamic and clinical effects. Med J Aust 1968 2 5 201-205
264. Jardin F, Genevray B, Brun-Ney D, Margairaz A. Dobutamine: a hemodynamic evaluation in pulmonary embolism shock. Crit Care Med 1985 13 12 1009-1012 (Pubitemid 16194640)
265. Manier G, Castaing Y. Influence of cardiac output on oxygen exchange in acute pulmonary embolism. Am Rev Respir Dis 1992 145 1 130-136
266. Webb S A., Stott S, van Heerden P V. The use of inhaled aerosolized prostacyclin (IAP) in the treatment of pulmonary hypertension secondary to pulmonary embolism. Intensive Care Med 1996 22 4 353-355
267. Ganière V, Feihl F, Tagan D. Dramatic beneficial effects of sildenafil in recurrent massive pulmonary embolism. Intensive Care Med 2006 32 3 452-454 (Pubitemid 43289656)
268. Capellier G, Jacques T, Balvay P, Blasco G, Belle E, Barale F. Inhaled nitric oxide in patients with pulmonary embolism. Intensive Care Med 1997 23 10 1089-1092 (Pubitemid 27490813)
269. Szold O, Khoury W, Biderman P, Klausner J M., Halpern P, Weinbroum A A. Inhaled nitric oxide improves pulmonary functions following massive pulmonary embolism: a report of four patients and review of the literature. Lung 2006 184 1 1-5
270. Huet Y, Brun-Buisson C, Lemaire F, Teisseire B, Lhoste F, Rapin M. Cardiopulmonary effects of ketanserin infusion in human pulmonary embolism. Am Rev Respir Dis 1987 135 1 114-117 (Pubitemid 17223899)
271. Kearon C, Kahn S R., Agnelli G, Goldhaber S, Raskob G E., Comerota A J., American College of Chest Physicians. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians evidence-based clinical practice guidelines (8th Edition). Chest 2008 133 6, Suppl 454S-545S (Pubitemid 351892971)
272. Verstraete M, Miller G A., Bounameaux H et al. Intravenous and intrapulmonary recombinant tissue-type plasminogen activator in the treatment of acute massive pulmonary embolism. Circulation 1988 77 2 353-360 (Pubitemid 18060044)
273. Meneveau N, Séronde M-F, Blonde M-C et al. Management of unsuccessful thrombolysis in acute massive pulmonary embolism. Chest 2006 129 4 1043-1050
274. Tapson V F. Acute pulmonary embolism. N Engl J Med 2008 358 10 1037-1052
275. Wan S, Quinlan D J., Agnelli G, Eikelboom J W. Thrombolysis compared with heparin for the initial treatment of pulmonary embolism: a meta-analysis of the randomized controlled trials. Circulation 2004 110 6 744-749 (Pubitemid 39056276)
276. Kucher N. Catheter embolectomy for acute pulmonary embolism. Chest 2007 132 2 657-663 (Pubitemid 47282401)
277. Leacche M, Unic D, Goldhaber S Z. et al. Modern surgical treatment of massive pulmonary embolism: results in 47 consecutive patients after rapid diagnosis and aggressive surgical approach. J Thorac Cardiovasc Surg 2005 129 5 1018-1023 (Pubitemid 40631421)
278. Eid-Lidt G, Gaspar J, Sandoval J et al. Combined clot fragmentation and aspiration in patients with acute pulmonary embolism. Chest 2008 134 1 54-60 (Pubitemid 352008763)
279. Maggio P, Hemmila M, Haft J, Bartlett R. Extracorporeal life support for massive pulmonary embolism. J Trauma 2007 62 3 570-576 (Pubitemid 46568852)
280. Pengo V, Lensing A WA, Prins M H. et al, Thromboembolic Pulmonary Hypertension Study Group. Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med 2004 350 22 2257-2264